Literature DB >> 8876100

Methadone maintenance and tuberculosis treatment.

D Raistrick1, A Hay, K Wolff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8876100      PMCID： PMC2352264          DOI： 10.1136/bmj.313.7062.925

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Rifampin-induced methadone withdrawal.

Authors:  M J Kreek; J W Garfield; C L Gutjahr; L M Giusti
Journal:  N Engl J Med       Date:  1976-05-13       Impact factor: 91.245

2.  Steady-state pharmacokinetics of methadone in opioid addicts.

Authors:  K Wolff; A W Hay; D Raistrick; R Calvert
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 3.  Infectious diseases and drug abuse. Prevention and treatment in the drug abuse treatment system.

Authors:  H W Haverkos
Journal:  J Subst Abuse Treat       Date:  1991

4.  Increasing incidence of tuberculosis in England and Wales: a study of the likely causes.

Authors:  N Bhatti; M R Law; J K Morris; R Halliday; J Moore-Gillon
Journal:  BMJ       Date:  1995-04-15
  4 in total
  11 in total

1.  Population pharmacokinetics of methadone in opiate users: characterization of time-dependent changes.

Authors:  A Rostami-Hodjegan; K Wolff; A W Hay; D Raistrick; R Calvert; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

Review 2.  Tuberculosis: 8. The disease in association with HIV infection.

Authors:  J M FitzGerald; S Houston
Journal:  CMAJ       Date:  1999-07-13       Impact factor: 8.262

Review 3.  Drug interactions with patient-controlled analgesia.

Authors:  Jorn Lotsch; Carsten Skarke; Irmgard Tegeder; Gerd Geisslinger
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 4.  Methadone for Pain Management: A Pharmacotherapeutic Review.

Authors:  Denise Kreutzwiser; Qutaiba A Tawfic
Journal:  CNS Drugs       Date:  2020-08       Impact factor: 5.749

5.  The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz.

Authors:  S M Clarke; F M Mulcahy; J Tjia; H E Reynolds; S E Gibbons; M G Barry; D J Back
Journal:  Br J Clin Pharmacol       Date:  2001-03       Impact factor: 4.335

Review 6.  Methadone: applied pharmacology and use as adjunctive treatment in chronic pain.

Authors:  R Brown; C Kraus; M Fleming; S Reddy
Journal:  Postgrad Med J       Date:  2004-11       Impact factor: 2.401

7.  Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society.

Authors: 
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

Review 8.  Tuberculosis and illicit drug use: review and update.

Authors:  Robert G Deiss; Timothy C Rodwell; Richard S Garfein
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

Review 9.  Pharmacokinetic interactions with rifampicin : clinical relevance.

Authors:  Mikko Niemi; Janne T Backman; Martin F Fromm; Pertti J Neuvonen; Kari T Kivistö
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

10.  Utilizing Pediatric Physiologically Based Pharmacokinetic Models to Examine Factors That Contribute to Methadone Pharmacokinetic Variability in Neonatal Abstinence Syndrome Patients.

Authors:  Brooks T McPhail; Chie Emoto; Tsuyoshi Fukuda; Dawn Butler; Jason R Wiles; Henry Akinbi; Alexander A Vinks
Journal:  J Clin Pharmacol       Date:  2019-12-09       Impact factor: 3.126
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.